Day 18, part 2 of #BobTuftsStemCellTransplant My covering physicians are satisfied with the early numbers. But next weekend is the key period to check. Barring a surprise I may go home Sept 23-24.

Superb clarification by @DrMRosenblatt of the roles of #government vs #biopharma companies in creating new #medicines

Honor those who took risks, were ahead of their times My Labor Day choice is easy: Marvin Miler

Day 20 of #BobTuftsStemCellTransplant. Finally able to rest in the 2 -3 hour windows between care. Actually dreaam1

There's still time! Register for the #2019GGSummit and get ready to chart your course in #raredisease! globalgenes.org/event/patient-…

2 people followed me // automatically checked by fllwrs.com

Day 21 of #BobTuftsStemCellTransplant. A great sleep last night, good preparation for the coming side effects and pressures of the stem cell transplant.

In 2008, a Chinese blood thinner killed 81 Americans, while today, FDA Drug Information is recalling 50+ imported blood pressure meds b/c of jet-fuel contaminants. The writing is on the wall: #drugimportation schemes put American #patients in danger. nypost.com/2019/09/03/the…

Sad but true! Myeloma has 19 drugs approved for treatment. The myeloma patient community is so fortunate to have such a productive, caring, and talented care team!

Day 22 of #BobTuftsStemCellTransplant Waiting for the stem cells to take and reproduce. I hear the Jeopardy theme song playing every once in awhile.

New SABR BioProject: Bob Tufts, Kansas City Royals pitcher in 1980s and one of the few Princeton Baseball alums to make the major leagues: sabr.org/bioproj/person… #SABR @tuftsb

It #NationalReadABookDay and here is one I am quite proud of.

Day 23 of #BobTuftsStemCellTransplant. Still tired, but all my metrics are in order for the process. #Science and #Innovation carry the day.

An update for Bob's followers:

Tonight BioNJ will be honoring Dad with The Heart of BioNJ Award at their annual dinner & innovation celebration. Thankful for their recognition of Dad’s tireless efforts for rare disease patient advocacy & medical innovation, & his strong commitment to BioNJ.